Literature DB >> 26064335

Predictive model of portal venous system thrombosis in cirrhotic portal hypertensive patients after splenectomy.

Shasha He1, Fangping He1.   

Abstract

OBJECTIVE: This study is to investigate the risk factors of portal venous system thrombosis (PVT) in patients with cirrhotic portal hypertension after splenectomy and to establish a Logistic regression prediction model.
METHODS: A total of 119 patients with cirrhotic portal hypertension were enrolled. Their clinical data was retrospectively analyzed. They were divided into PVT group (n = 18) and non-PVT group (n = 101). One-way analysis and multivariate Logistic regression analysis were performed to analyze the independent risk factors of PVT. Logistic regression prediction model was established. The receiver operating characteristic curve was generated and correlation analysis was conducted.
RESULTS: Platelet count (PLT), mean platelet volume (MPV) and D-Dimer were independent risk factors affecting PVT. Anticoagulation therapy (UAT) and usage of reducing portal pressure therapy (URPT) were independent protective factors of PVT. Logistic regression prediction model was expressed as Logit P = -9.165 + 0.664 × PLT (× 10(11)/L) + 0.413 × MPV (fL) + 0.662 × D-Dimer (mg/L) -1.674 × UAT (Yes = 1, No = 0) -1.518 × URPT (Yes = 1, No = 0). And, the cut-off value of Logit P was -1.14. The area under the receiver operating characteristic curve and the accuracy were 0.865 and 84.03%. The cut-off value of PLT, MPV and D-Dimer were 4.42 × 10(11)/L, 13.30 fL and 2.55 mg/L, respectively. MPV and D-Dimer were positively correlated.
CONCLUSION: PLT, MPV and D-Dimer are independent risk factors while UAT and URPT are independent protective factors of PVT. Logistic regression prediction model can predict PVT with a high sensitivity, specificity and accuracy. It provides theoretical foundation and cut-off value for predicting PVT after splenectomy.

Entities:  

Keywords:  Cirrhosis; portal hypertensive; portal venous system thrombosis; splenectomy; the independent risk factors; the logistic regression predict model

Year:  2015        PMID: 26064335      PMCID: PMC4443169     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  20 in total

1.  Splenectomy for thrombocytopenia in patients with hepatitis C cirrhosis.

Authors:  Paul H Hayashi; Carlos Mehia; H Joachim Reimers; Harvey S Solomon; Bruce R Bacon
Journal:  J Clin Gastroenterol       Date:  2006-09       Impact factor: 3.062

2.  Postoperative portal vein thrombosis in patients with hepatosplenic mansonic schistosomiasis: relationship with intraoperative portal pressure and flow. A prospective study.

Authors:  Roberto de Cleva; Paulo Herman; William Abrão Saad; Vincenzo Pugliese; Bruno Zilberstein; Joaquim José Gama Rodrigues; Antonio Atílio Laudanna
Journal:  Hepatogastroenterology       Date:  2005 Sep-Oct

3.  Portal vein thrombosis after splenectomy.

Authors:  Emily R Winslow; L Michael Brunt; Jeffery A Drebin; Nathaniel J Soper; Mary E Klingensmith
Journal:  Am J Surg       Date:  2002-12       Impact factor: 2.565

4.  Randomized controlled trial to investigate the impact of anticoagulation on the incidence of splenic or portal vein thrombosis after laparoscopic splenectomy.

Authors:  Haili Wang; Daniel Kopac; Ronald Brisebois; Clifford Sample; A M James Shapiro
Journal:  Can J Surg       Date:  2011-08       Impact factor: 2.089

5.  D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients.

Authors:  Andrew F Shorr; Stephen J Thomas; Stephan A Alkins; Thomas M Fitzpatrick; Geoffrey S Ling
Journal:  Chest       Date:  2002-04       Impact factor: 9.410

6.  The beneficial role of simultaneous splenectomy in living donor liver transplantation in patients with small-for-size graft.

Authors:  Tomoharu Yoshizumi; Akinobu Taketomi; Yuji Soejima; Toru Ikegami; Hideaki Uchiyama; Hiroto Kayashima; Noboru Harada; Yo-ichi Yamashita; Hirofumi Kawanaka; Takashi Nishizak; Yoshihiko Maehara
Journal:  Transpl Int       Date:  2008-05-13       Impact factor: 3.782

7.  Effectiveness of combination therapy of splenectomy and long-term interferon in patients with hepatitis C virus-related cirrhosis and thrombocytopenia.

Authors:  Daisuke Morihara; Masahiro Kobayashi; Kenji Ikeda; Yusuke Kawamura; Hiromi Saneto; Hiromi Yatuji; Tetuya Hosaka; Hitomi Sezaki; Norio Akuta; Yoshiyuki Suzuki; Fumitaka Suzuki; Hiromitu Kumada
Journal:  Hepatol Res       Date:  2009-01-16       Impact factor: 4.288

8.  Efficacy of splenectomy for hypersplenic patients with advanced hepatocellular carcinoma.

Authors:  Masashi Hirooka; Kiyotaka Ishida; Yoshiyasu Kisaka; Takahide Uehara; Yuji Watanabe; Yoichi Hiasa; Kojiro Michitaka; Morikazu Onji
Journal:  Hepatol Res       Date:  2008-07-04       Impact factor: 4.288

9.  Laparoscopic splenectomy reverses thrombocytopenia in patients with hepatitis C cirrhosis and portal hypertension.

Authors:  Kent W Kercher; Alfredo M Carbonell; B Todd Heniford; Brent D Matthews; Dawn M Cunningham; Robert W Reindollar
Journal:  J Gastrointest Surg       Date:  2004-01       Impact factor: 3.452

Review 10.  Inflammation and haemostasis.

Authors:  Sandra Margetic
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

View more
  14 in total

1.  Splanchnic Vein Thrombosis in Liver Cirrhosis After Splenectomy or Splenic Artery Embolization: A Systematic Review and Meta-Analysis.

Authors:  Yanyan Wu; Hongyu Li; Tiansong Zhang; Zhaohui Bai; Xiangbo Xu; Giovanni Battista Levi Sandri; Le Wang; Xingshun Qi
Journal:  Adv Ther       Date:  2021-03-09       Impact factor: 3.845

2.  Predictive Effect of Mean Platelet Volume in Patients with Portal Vein Thrombosis: A Meta-analysis of Case-control Studies.

Authors:  Wen-Yi Lin; Xuan Lu; Feng-Juan Fan; Yu Hu
Journal:  Curr Med Sci       Date:  2018-08-20

3.  Early prevention and risk factors analysis of portal vein system thrombosis after laparoscopic splenectomy and pericardial devascularization.

Authors:  Yongning Li; Xueqin Fu; Ying Li; Peng Liu; Songbai Liu; Yaozhen Pan
Journal:  Surg Endosc       Date:  2022-06-28       Impact factor: 4.584

4.  Living donor liver transplantation combined with splenectomy in a child with Niemann-Pick disease type B: single-centre experience of perioperative anticoagulation regimen.

Authors:  Han Ding; Jian Wang; Yichi Zhang; Shuai Zhao; Bing Han; Hao Cai; Jinyang Gu
Journal:  Hepatobiliary Surg Nutr       Date:  2022-06       Impact factor: 8.265

Review 5.  Research Progress in Chinese Medicine Preparations for Promoting Blood Circulation and Removing Blood Stasis for Cirrhotic Patients with Portal Vein Thrombosis Following Splenectomy.

Authors:  Ding-Qi Zhang; Yong-Ping Mu; Ying Xu; Jia-Mei Chen; Ping Liu; Wei Liu
Journal:  Chin J Integr Med       Date:  2020-07-20       Impact factor: 2.626

6.  Evaluation of Platelet Indices in Patients with Splanchnic Vein Thrombosis.

Authors:  Saniya Sharma; Narender Kumar; Ishwar Bihana; Varun Uppal; Jasmina Ahluwalia; Shano Naseem; Neelam Varma; Surinder Singh Rana
Journal:  Indian J Hematol Blood Transfus       Date:  2021-04-13       Impact factor: 0.915

7.  The causes of lower-extremity deep venous thrombosis in the children with cranial diseases.

Authors:  Yan Wang; Wei Liu; Ge Jia; Na Li; Yulong Jia
Journal:  Int J Clin Exp Med       Date:  2015-11-15

8.  Laparoscopic distal splenoadrenal shunt for the treatment of portal hypertension in children with congenital hepatic fibrosis: A case report.

Authors:  Jin-Shan Zhang; Wei Cheng; Long Li
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

9.  Risk Factors of Portal Vein Thrombosis after Devascularization Treatment in Patients with Liver Cirrhosis: A Nested Case-Control Study.

Authors:  Shenxin Lu; Guohua Hu; Shiyao Chen; Jian Wang
Journal:  Biomed Res Int       Date:  2020-08-27       Impact factor: 3.411

10.  Nomogram Model for Prediction of Portal Vein Thrombosis in Patients with Liver Cirrhosis After Splenectomy: A Retrospective Analysis of 2 Independent Cohorts.

Authors:  Hai-Liang Yuan; Min Wang; Wei-Wei Chu; Fang-Xian Li; Jing-Jing Lu; Yan Li
Journal:  Med Sci Monit       Date:  2021-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.